[Sensitivity of dimorphic Candida albicans cells to polyene antibiotics and their combinations with other biologically active substances]. 1987

R A Araviĭskiĭ, and O L Potyl'chanskaia

It was shown that polyenic antibiotics and their combinations with some other antifungal and antibacterial agents prevented transformation of the C. albicans yeast phase into the tissue one. Moreover, the fungus tissue form proved to be more sensitive than the yeast form to the drugs and especially to their combinations. The in vitro findings were confirmed by the in vivo studies. Combinations of amphotericin B with methacycline, rifampicin, 5-fluorocytosine or polymyxin B were more efficient than the polyene alone. Summation of the drug antifungal effects provided a 4-fold decrease in the polyene quantity required for administration to experimental animals.

UI MeSH Term Description Entries
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

R A Araviĭskiĭ, and O L Potyl'chanskaia
June 1984, Vestnik dermatologii i venerologii,
R A Araviĭskiĭ, and O L Potyl'chanskaia
January 1980, Mikrobiologiia,
R A Araviĭskiĭ, and O L Potyl'chanskaia
October 1979, Antibiotiki,
R A Araviĭskiĭ, and O L Potyl'chanskaia
August 1976, British medical journal,
R A Araviĭskiĭ, and O L Potyl'chanskaia
June 1965, Journal of bacteriology,
R A Araviĭskiĭ, and O L Potyl'chanskaia
November 1980, Vestnik dermatologii i venerologii,
R A Araviĭskiĭ, and O L Potyl'chanskaia
October 1974, Nature,
R A Araviĭskiĭ, and O L Potyl'chanskaia
March 1986, The Journal of infectious diseases,
R A Araviĭskiĭ, and O L Potyl'chanskaia
August 1977, Antibiotiki,
Copied contents to your clipboard!